Enhancement of the infectivity titer of adenovirus type 8.
D000256:Adenoviridae / Q000187:drug effects / Q000472:pathogenicity*; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002277:Carcinoma; D002460:Cell Line; D002918:Chymotrypsin / Q000494:pharmacology; D046508:Culture Techniques; D003588:Cytopathogenic Effect, Viral; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000494:pharmacology; D007637:Keratoconjunctivitis / Q000382:microbiology; D009062:Mouth Neoplasms; D009174:Mycoplasma / Q000472:pathogenicity; D011817:Rabbits; D014461:Ultracentrifugation; D014776:Virus Cultivation; D014779:Virus Replication
D006846:Hydrocarbons, Halogenated; D001120:Arginine; D002918:Chymotrypsin